Follow
Faryal Mir
Faryal Mir
Internal Medicine Resident, KPC Health
Verified email at kpc.health
Title
Cited by
Cited by
Year
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in vivo with Fractional Factorial and Definitive Screening Designs
K KJ, Dorkin JR, Y JH, H MW, DR F, M FF, F OS, A DG
Nano Letters, 2015
5932015
Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium
AK Patel, JC Kaczmarek, S Bose, KJ Kauffman, F Mir, MW Heartlein, ...
Advanced Materials 31 (8), 1805116, 2019
2812019
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
JE Dahlman, KJ Kauffman, Y Xing, TE Shaw, FF Mir, CC Dlott, R Langer, ...
Proceedings of the National Academy of Sciences 114 (8), 2060-2065, 2017
2272017
Synthesis and biological evaluation of ionizable lipid materials for the in vivo delivery of messenger RNA to B lymphocytes
OS Fenton, KJ Kauffman, JC Kaczmarek, RL McClellan, S Jhunjhunwala, ...
Advanced Materials 29 (33), 1606944, 2017
1952017
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
KJ Kauffman, FF Mir, S Jhunjhunwala, JC Kaczmarek, JE Hurtado, ...
Biomaterials 109, 78-87, 2016
1752016
Identification of novel fibrosis modifiers by in vivo siRNA silencing
EH Vollmann, L Cao, A Amatucci, T Reynolds, S Hamann, I Dalkilic-Liddle, ...
Molecular Therapy-Nucleic Acids 7, 314-323, 2017
412017
Chimeric mouse model for MRI contrast agent evaluation
FF Mir, RP Tomaszewski, DD Shuboni‐Mulligan, CL Mallett, JML Hix, ...
Magnetic resonance in medicine 82 (1), 387-394, 2019
82019
Rational Design of Multifunctional Nanoparticles for Targeted Cancer Imaging and Therapy
I AK, M FF, V G
Post-genomic Approaches in Cancer and Nano Medicine 1, 219-255, 2015
2015
Lipid nanoparticle formulation optimization for in vivo mrna Delivery with design of experiment methodologies
K Kauffman, JR Dorkin, JH Yang, FF Mir, DG Anderson
The system can't perform the operation now. Try again later.
Articles 1–9